Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

project manager


phd fellow

About the project

SQUEEZE is a European consortium that has been awarded funding from Horizon Europe, the EU's research program to research the treatment of rheumatoid arthritis. There will be several parts of the project addressing different approaches to arthritis treatment. REMEDY has the main responsibility for the part of the project that works with therapeutic drug monitoring. This includes a large randomized controlled trial, RA-DRUM.

More information about the entire SQUEEZE can be found on the consortium website:

Who can participate?

Patients over 18 years of age diagnosed with rheumatoid arthritis (arthritis). Recruitment of participants has not yet begun.

Project arrangement

More information on the study is forthcoming.

This project has received funding from the European Union's Horizon Europe research and innovation program under grant agreement no. 101095052. Views and opionions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.


All rights reserved © REMEDY; Illustration/portrait images © Nicolas Tourrenc/Diakonhjemmet Hospital